Beroni Group Limited - FPO

BTG3.960
  • CHANGE
    0.00%
  • LAST
    0.99
  • VOLUME
    20900
  • LAST TRADE
    23-Sep-2022 10:00:00 AM

Announcements For BTG


Code Headline Release Date

BTG

41999 NSX General Market Disclosure Other - Corporate Governance Statement
Corporate Governance Statement
01-Apr-2026 9:25:25 AM;20260401092525

BTG

40510 NSX Annual Report - 2025 Annual Financial Report
2025 Annual Financial Report
01-Apr-2026 9:25:13 AM;20260401092513

BTG

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Final Report - 31 December 2025
Preliminary Final Report - 31 December 2025
12-Mar-2026 4:15:31 PM;20260312161531

BTG

Price Sensitive
40540 NSX Half Yearly Report - Interim Financial Report Ended 30 June 2025
Interim Financial Report Ended 30 June 2025
12-Sep-2025 4:12:09 PM;20250912161209

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
22-Jul-2025 9:48:14 AM;20250722094814

BTG

40399 NSX Issued Capital Other - Issue of Shares
Issue of Shares
22-Jul-2025 9:48:26 AM;20250722094826

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Breakthrough in Nucleic Acid Innovative Drug Platform
Significant Breakthrough in Building its Nucleic Acid Innovative Drug Platform
21-Jul-2025 9:00:25 AM;20250721090025

BTG

41999 NSX General Market Disclosure Other - Discontinuation of Listing on OTCQB
Discontinuation of Listing on OTCQB
03-Jul-2025 9:01:34 AM;20250703090134

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
10-Jun-2025 10:02:28 AM;20250610100228

BTG

41999 NSX General Market Disclosure Other - Issue of Shares
Issue of Shares
10-Jun-2025 10:02:16 AM;20250610100216

BTG

40930 NSX Results of Meeting - Results of Annual General Meeting
Results of Annual General Meeting
30-May-2025 3:52:02 PM;20250530155202

BTG

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
30-Apr-2025 10:17:41 AM;20250430101741

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
23-Apr-2025 1:17:29 PM;20250423131729

BTG

41999 NSX General Market Disclosure Other - Issue of Shares
Issue of Shares
23-Apr-2025 1:17:17 PM;20250423131717

BTG

41999 NSX General Market Disclosure Other - Quotation of Shares Upon Expiry of Holding Lock
Quotation of Shares Upon Expiry of Holding Lock
17-Apr-2025 8:54:47 AM;20250417085447

BTG

41999 NSX General Market Disclosure Other - Corporate Governance Statement
Corporate Governance Statement
31-Mar-2025 4:02:10 PM;20250331160210

BTG

Price Sensitive
40510 NSX Annual Report - FY2024 Annual Report
FY2024 Annual Report
31-Mar-2025 4:01:58 PM;20250331160158

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
26-Mar-2025 3:39:45 PM;20250326153945

BTG

41999 NSX General Market Disclosure Other - Issue of Shares
Issue of Shares
26-Mar-2025 3:39:57 PM;20250326153957

BTG

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Final Report - 31 December 2024
Preliminary Final Report - 31 December 2024
14-Mar-2025 4:28:46 PM;20250314162846

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Acquisition of Brain Wave Extraction Patent
Beroni Group Announces Acquisition of "Brain Wave Extraction" Patent Technology from Japan Electrocardiogram Research Institute to Accelerate Layout in Brain-Computer Interface Field
10-Mar-2025 3:28:35 PM;20250310152835

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
08-Nov-2024 8:58:36 AM;20241108085836

BTG

41999 NSX General Market Disclosure Other - Issue of Shares
Issue of Shares
08-Nov-2024 8:58:48 AM;20241108085848

BTG

40930 NSX Results of Meeting - Updated Results of Annual General Meeting
Updated Results of Annual General Meeting
06-Nov-2024 3:23:14 PM;20241106152314

BTG

40051 NSX Reinstatement to Official Quotation - Reinstatement to Official Quotation
Reinstatement to Official Quotation
01-Nov-2024 6:52:36 PM;20241101185236

BTG

40540 NSX Half Yearly Report - Interim Financial Report Ended 30 June 2024
Interim Financial Report Ended 30 June 2024
25-Oct-2024 4:12:46 PM;20241025161246

BTG

41999 NSX General Market Disclosure Other - Change of Auditor
Change of Auditor
21-Oct-2024 10:01:31 AM;20241021100131

BTG

40399 NSX Issued Capital Other - Application of Quotation of Securities
Application of Quotation of Securities
10-Oct-2024 4:17:07 PM;20241010161707

BTG

40399 NSX Issued Capital Other - Issue of Shares
Issue of Shares
10-Oct-2024 4:16:36 PM;20241010161636

BTG

40930 NSX Results of Meeting - Results of Annual General Meeting
Results of Annual General Meeting
01-Oct-2024 2:00:03 PM;20241001140003

BTG

Price Sensitive
40050 NSX Suspension from Official Quotation - Continued Suspension
Continued Suspension
16-Sep-2024 10:01:44 AM;20240916100144

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
06-Sep-2024 9:11:23 AM;20240906091123

BTG

40315 NSX Placement - Issue of Shares
Issue of Shares
06-Sep-2024 9:11:04 AM;20240906091104

BTG

Price Sensitive
40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
30-Aug-2024 12:46:19 PM;20240830124619

BTG

41999 NSX General Market Disclosure Other - Corporate Governance Statement
Corporate Governance Statement
07-Aug-2024 4:34:20 PM;20240807163420

BTG

Price Sensitive
40510 NSX Annual Report - FY2023 Annual Report
FY2023 Annual Report
07-Aug-2024 4:33:56 PM;20240807163356

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Directors Interest Notice - John Chiplin
Final Directors Interest Notice - John Chiplin
01-Aug-2024 9:47:13 AM;20240801094713

BTG

41999 NSX General Market Disclosure Other - Demise of Director Dr John Chiplin
Demise of Director Dr John Chiplin
01-Aug-2024 9:45:36 AM;20240801094536

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
23-May-2024 11:38:39 AM;20240523113839

BTG

40399 NSX Issued Capital Other - Issue of Shares
Issue of Shares
23-May-2024 11:38:16 AM;20240523113816

BTG

41999 NSX General Market Disclosure Other - Issue of Shares
Issue of Shares
30-Apr-2024 11:27:18 AM;20240430112718

BTG

40335 NSX Alteration to Issued Capital - Application for quotation of additional securities
Application for quotation of additional securities
30-Apr-2024 10:59:53 AM;20240430105953

BTG

41999 NSX General Market Disclosure Other - Update on Suspension
Update on Suspension
23-Apr-2024 3:48:11 PM;20240423154811

BTG

41999 NSX General Market Disclosure Other - Extension of Convertible Loan and Cancellation of Conv
Extension of Convertible Loan and Cancellation of Convertible Notes
23-Apr-2024 3:31:29 PM;20240423153129

BTG

Price Sensitive
40050 NSX Suspension from Official Quotation - Suspension from Official Quotation - Failure to lodge Annual Financial Statements for 31 December 2023
Suspension from Official Quotation - Failure to lodge Annual Financial Statements for 31 December 2023
04-Apr-2024 8:59:37 AM;20240404085937

BTG

Price Sensitive
40030 NSX Trading Halt - Trading Halt - Failure to lodge Annual Financial Statements for 31 December 2023
Trading Halt - Failure to lodge Annual Financial Statements for 31 December 2023
02-Apr-2024 10:05:01 AM;20240402100501

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
25-Mar-2024 8:42:20 AM;20240325084220

BTG

41999 NSX General Market Disclosure Other - Issue of Shares and Cleansing Notice
Issue of Shares and Cleansing Notice
25-Mar-2024 8:41:28 AM;20240325084128

BTG

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Final Report - 31 December 2023
Preliminary Final Report - 31 December 2023
15-Mar-2024 4:36:49 PM;20240315163649

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
17-Jan-2024 4:14:11 PM;20240117161411

BTG

41999 NSX General Market Disclosure Other - Completion of Consolidation of Capital
Completion of Consolidation of Capital
17-Jan-2024 4:13:04 PM;20240117161304

BTG

41999 NSX General Market Disclosure Other - Update on Consolidation of Capital
Update on Consolidation of Capital
15-Nov-2023 1:16:33 PM;20231115131633

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Enters into Convertible Loans
Beroni Enters into Convertible Loans
09-Nov-2023 8:49:21 AM;20231109084921

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Enters Into Convertible Loans
Beroni Enters Into Convertible Loans
19-Oct-2023 4:11:55 PM;20231019161155

BTG

Price Sensitive
40325 NSX Capital Reconstruction - Consolidation of Capital
Consolidation of Capital
16-Oct-2023 12:00:01 PM;20231016120001

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Enters Into Convertible Loan With Investor
Beroni Enters Into Convertible Loan With Investor
22-Sep-2023 12:41:25 PM;20230922124125

BTG

40750 NSX Details of Share Registry - Change of Registry Address
Change of Registry Address
19-Sep-2023 12:23:52 PM;20230919122352

BTG

Price Sensitive
40540 NSX Half Yearly Report - Half Year Report Ended 30 June 2023
Half Year Report Ended 30 June 2023
13-Sep-2023 5:57:42 PM;20230913175742

BTG

Price Sensitive
40510 NSX Annual Report - Restatement and Reissuance of 2022 Annual Report
Restatement and Reissuance of 2022 Annual Report
17-Aug-2023 7:22:57 PM;20230817192257

BTG

40599 NSX Periodic Disclosure Other - Annual Nominated Adviser Statement for 2023 - 2024
Annual Nominated Adviser Statement for 2023 - 2024
03-Aug-2023 12:44:05 PM;20230803124405

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
11-Jul-2023 9:21:49 AM;20230711092149

BTG

41999 NSX General Market Disclosure Other - Issue of Shares and Cleansing Statement
Issue of Shares and Cleansing Statement
11-Jul-2023 9:21:14 AM;20230711092114

BTG

41999 NSX General Market Disclosure Other - Re-Issue of Shares
Re-Issue of Shares
03-Jul-2023 8:27:53 AM;20230703082753

BTG

41999 NSX General Market Disclosure Other - Reversal of Issue of Shares
Reversal of Issue of Shares
14-Jun-2023 6:48:18 PM;20230614184818

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change of Director's Interest Notices - Zhang, Huang, Guo, Ong, Buchta & Wong
Change of Director's Interest Notices - Zhang, Huang, Guo, Ong, Buchta & Wong
13-Jun-2023 10:34:11 AM;20230613103411

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
13-Jun-2023 10:16:24 AM;20230613101624

BTG

41999 NSX General Market Disclosure Other - Issue of Shares
Issue of Shares
13-Jun-2023 10:06:59 AM;20230613100659

BTG

40930 NSX Results of Meeting - Results of Annual General Meeting
Results of Annual General Meeting
31-May-2023 4:47:13 PM;20230531164713

BTG

40930 NSX Results of Meeting - Results of General Meeting
Results of General Meeting
23-May-2023 8:40:36 AM;20230523084036

BTG

40130 NSX Ceasing to be a Substantial Shareholder - Ceasing to be a Substantial Shareholder
Ceasing to be a Substantial Shareholder
05-May-2023 4:38:25 PM;20230505163825

BTG

40110 NSX Becoming a Substantial Shareholder - Becoming a Substantial Shareholder
Becoming a Substantial Shareholder
05-May-2023 4:38:06 PM;20230505163806

BTG

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
28-Apr-2023 2:14:01 PM;20230428141401

BTG

Price Sensitive
40920 NSX Notice of Extraordinary Meeting - Notice of General Meeting
Notice of General Meeting
21-Apr-2023 2:40:01 PM;20230421144001

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Enters Into Convertible Loans With Investors
Beroni Enters Into Convertible Loans With Investors
20-Apr-2023 7:19:55 AM;20230420071955

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - 2022 Corporate Governance Statement
2022 Corporate Governance Statement
31-Mar-2023 4:05:40 PM;20230331160540

BTG

Price Sensitive
40510 NSX Annual Report - 31 December 2022 Annual Report
31 December 2022 Annual Report
31-Mar-2023 3:18:02 PM;20230331151802

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Extension of 5000 Convertible Note Expiry Date
Extension of 5000 Convertible Note Expiry Date
29-Mar-2023 8:46:59 AM;20230329084659

BTG

40810 NSX Director Appointment/Resignation - Director Resignation - Dr Zhinan Yin
Director Resignation - Dr Zhinan Yin
23-Mar-2023 9:59:11 AM;20230323095911

BTG

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Final Report - 31 December 2022
Preliminary Final Report - 31 December 2022
16-Mar-2023 12:10:18 PM;20230316121018

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Advances R&D of Enhanced COVID-19 Antigen RTK
Beroni Advances R&D of its Enhanced COVID-19 Antigen Rapid Test Kit
08-Feb-2023 4:39:41 PM;20230208163941

BTG

41999 NSX General Market Disclosure Other - NASDAQ Listing Application Update
NASDAQ Listing Application Update
01-Feb-2023 3:28:34 PM;20230201152834

BTG

Price Sensitive
40540 NSX Half Yearly Report - Half Year Report Ended 30 June 2022
Half Year Report Ended 30 June 2022
13-Sep-2022 4:21:25 PM;20220913162125

BTG

40599 NSX Periodic Disclosure Other - Annual Nominated Adviser Statement for 2022 - 2023
Annual Nominated Adviser Statement for 2022 - 2023
05-Sep-2022 10:38:39 AM;20220905103839

BTG

Price Sensitive
40399 NSX Issued Capital Other - Issue off Employee Options
Issue off Employee Options
23-Aug-2022 12:05:23 PM;20220823120523

BTG

Price Sensitive
40930 NSX Results of Meeting - Results of General Meeting
Results of General Meeting
26-Jul-2022 4:35:09 PM;20220726163509

BTG

Price Sensitive
40920 NSX Notice of Extraordinary Meeting - Addendum to Notice of General Meeting
Addendum to Notice of General Meeting
12-Jul-2022 12:40:00 PM;20220712124000

BTG

Price Sensitive
40920 NSX Notice of Extraordinary Meeting - Notice of General Meeting
Notice of General Meeting
27-Jun-2022 7:31:31 PM;20220627193131

BTG

40399 NSX Issued Capital Other - Issue of Employee Options
Issue of Employee Options
23-Jun-2022 12:53:29 PM;20220623125329

BTG

41999 NSX General Market Disclosure Other - Clarification of Revision to Share Option Terms
Clarification of Revision to Share Option Terms
06-Jun-2022 1:33:55 PM;20220606133355

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Antigen Rapid Test Kit Received CE Certification
Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification
01-Jun-2022 9:05:19 AM;20220601090519

BTG

40930 NSX Results of Meeting - Results of Annual General Meeting
Results of Annual General Meeting
01-Jun-2022 9:05:09 AM;20220601090509

BTG

41999 NSX General Market Disclosure Other - Amendment of Terms of Convertible Notes
Amendment of Terms of Convertible Notes
19-May-2022 9:12:20 AM;20220519091220

BTG

40910 NSX Notice of Annual General Meeting - Addendum to Notice of Annual General Meeting
Addendum to Notice of Annual General Meeting
13-May-2022 2:26:39 PM;20220513142639

BTG

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
02-May-2022 5:08:00 PM;20220502170800

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - John Chiplin
Director's Declaration & Undertaking - John Chiplin
01-Apr-2022 12:29:00 PM;20220401122900

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interest Notice - John Chiplin
Initial Director's Interest Notice - John Chiplin
01-Apr-2022 9:07:20 AM;20220401090720

BTG

Price Sensitive
40810 NSX Director Appointment/Resignation - Appointment of Dr. John Chiplin to Board of Directors
Appointment of Dr. John Chiplin to Board of Directors
01-Apr-2022 9:07:16 AM;20220401090716

BTG

41999 NSX General Market Disclosure Other - 2021 Corporate Governance Statement
2021 Corporate Governance Statement
31-Mar-2022 11:10:18 AM;20220331111018

BTG

Price Sensitive
40510 NSX Annual Report - 31 December 2021 Annual Report
31 December 2021 Annual Report
31-Mar-2022 11:10:14 AM;20220331111014

BTG

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Final Report - 31 December 2021
Preliminary Final Report - 31 December 2021
16-Mar-2022 1:25:42 PM;20220316132542

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
03-Mar-2022 2:27:24 PM;20220303142724

BTG

41999 NSX General Market Disclosure Other - Issue of Shares and Cleansing Statement
Issue of Shares and Cleansing Statement
03-Mar-2022 2:24:23 PM;20220303142423

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - New R&D Centre in High-Tech Hub in Zhuhai, China
Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China
31-Jan-2022 9:11:16 AM;20220131091116

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Group Issues US$500K of Convertible Notes
Beroni Group Issues US$500K of Convertible Notes
31-Jan-2022 9:11:11 AM;20220131091111

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Filing of Registration Statement in the U.S.
Beroni Group Announces Filing of Registration Statement in the U.S. for Proposed Initial Public Offering of Securities
22-Dec-2021 9:22:49 AM;20211222092249

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
22-Dec-2021 8:52:22 AM;20211222085222

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Conversion of Convertible Notes & Cleansing Statement
Conversion of Convertible Notes & Cleansing Statement
22-Dec-2021 8:38:18 AM;20211222083818

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interest - Jacky Zhang
Change in Director's Interest - Jacky Zhang
17-Dec-2021 2:21:17 PM;20211217142117

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interest - Nicholas Ong
Change in Director's Interest - Nicholas Ong
03-Dec-2021 8:56:05 AM;20211203085605

BTG

40720 NSX Details of Company Address - Change of Company Address
Change of Registered Address and Principal Place of Business
24-Nov-2021 3:04:19 PM;20211124150419

BTG

41999 NSX General Market Disclosure Other - Extension of Maturity Date of Convertible Notes
Extension of Maturity Date of Convertible Notes
22-Nov-2021 3:54:37 PM;20211122155437

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - US$1.07M COVID-19 Antigen Test Kits Order from Japan
Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan
18-Nov-2021 2:15:29 PM;20211118141529

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Published Article on the FEBS Journal
Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal
28-Oct-2021 4:08:45 PM;20211028160845

BTG

Price Sensitive
40540 NSX Half Yearly Report - Half Year Report for the Year Ended 30 June 2021
Half Year Report for the Year Ended 30 June 2021
10-Sep-2021 7:48:55 PM;20210910194855

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Approval for R&D Rebate for Anti-Cancer Drug PENAO
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO
09-Sep-2021 4:05:19 PM;20210909160519

BTG

40399 NSX Issued Capital Other - Issue of Options
Issue of Options
08-Sep-2021 10:05:28 AM;20210908100528

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Latest Clinical Study of SARS-CoV-2 Antigen Test Kit
Beroni Group Announced the Latest Clinical Study of its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)
31-Aug-2021 12:35:21 PM;20210831123521

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
26-Aug-2021 11:35:38 AM;20210826113538

BTG

Price Sensitive
40399 NSX Issued Capital Other - Issue of Shares
Issue of Shares
26-Aug-2021 11:35:35 AM;20210826113535

BTG

40024 NSX Nominated Adviser's Declaration - Annual Nominated Adviser Statement - 2021-2022
Annual Nominated Adviser Statement - 2021-2022
24-Aug-2021 11:35:41 AM;20210824113541

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Initiates Manufacture of PENAO
Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
18-Aug-2021 3:22:12 PM;20210818152212

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Directors Interest Notice - Tameyuki Kawaguchi
Final Directors Interest Notice - Tameyuki Kawaguchi
03-Aug-2021 10:51:27 AM;20210803105127

BTG

40810 NSX Director Appointment/Resignation - Resignation of Director
Resignation of Director
03-Aug-2021 9:41:35 AM;20210803094135

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interest - Nicholas Ong
Change in Director's Interest - Nicholas Ong
21-Jul-2021 12:31:25 PM;20210721123125

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interest -Libing Guo
Change in Director's Interest -Libing Guo
21-Jul-2021 12:31:11 PM;20210721123111

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interest - Richard Buchta
Change in Director's Interest - Richard Buchta
21-Jul-2021 10:46:19 AM;20210721104619

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interest - Zhinan Yin
Change in Director's Interest - Zhinan Yin
21-Jul-2021 10:46:16 AM;20210721104616

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interest - Hai Huang
Change in Director's Interest - Hai Huang
21-Jul-2021 10:46:13 AM;20210721104613

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interest - Peter Wong
Change in Director's Interest - Peter Wong
21-Jul-2021 10:46:10 AM;20210721104610

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interest - Jacky Zhang
Change in Director's Interest - Jacky Zhang
21-Jul-2021 10:46:07 AM;20210721104607

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
21-Jul-2021 10:46:03 AM;20210721104603

BTG

Price Sensitive
40399 NSX Issued Capital Other - Issue of Options
Issue of Options
21-Jul-2021 10:46:00 AM;20210721104600

BTG

40930 NSX Results of Meeting - Results of Annual General Meeting
Results of Annual General Meeting
16-Jul-2021 2:48:06 PM;20210716144806

BTG

40910 NSX Notice of Annual General Meeting - Update on Annual General Meeting
IMPACT OF COVID-19 RESTRICTIONS ON THE COMPANY’S ANNUAL GENERAL MEETING
09-Jul-2021 7:54:05 AM;20210709075405

BTG

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
15-Jun-2021 1:48:08 PM;20210615134808

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - US$2 Million of Convertible Plans
Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans
28-May-2021 10:06:33 AM;20210528100633

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Collaboration with tella Inc for Cancer Treatment
Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
28-May-2021 10:02:39 AM;20210528100239

BTG

41999 NSX General Market Disclosure Other - Extension of Maturity Date of Convertible Notes
Extension of Maturity Date of Convertible Notes
17-May-2021 4:22:05 PM;20210517162205

BTG

41999 NSX General Market Disclosure Other - 5-Year Comparative Performance and Financial Position
5-Year Comparative Performance and Financial Position
13-May-2021 4:17:13 PM;20210513161713

BTG

41999 NSX General Market Disclosure Other - 2020 Corporate Governance Statement
2020 Corporate Governance Statement
30-Apr-2021 9:23:42 AM;20210430092342

BTG

Price Sensitive
40510 NSX Annual Report - 2021 Annual Report
2021 Annual Report
30-Apr-2021 9:23:37 AM;20210430092337

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - SARS-CoV-2 Antigen Test Kit Received Export Permit
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
27-Apr-2021 1:20:40 PM;20210427132040

BTG

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Final Report - 31 December 2020
Preliminary Final Report - 31 December 2020
16-Mar-2021 6:33:18 PM;20210316183318

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - ASIC Relief to Extend Reporting Deadline
ASIC Relief to Extend Reporting Deadline for Audited Financial Report
16-Mar-2021 6:01:57 PM;20210316180157

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests Notice - Nicholas Ong
Initial Director's Interests Notice - Nicholas Ong
02-Mar-2021 8:14:02 AM;20210302081402

BTG

40023 NSX Director's Declaration & Undertaking - Director Declaration - Chen Chik Nicholas Ong
Director Declaration - Chen Chik Nicholas Ong
02-Mar-2021 8:14:55 AM;20210302081455

BTG

Price Sensitive
40810 NSX Director Appointment/Resignation - Appointment of Non-Executive Director of Beroni Group
Appointment of Non-Executive Director of Beroni Group
02-Mar-2021 8:13:42 AM;20210302081342

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Acquires Majority Interest in PENAO
Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company
03-Feb-2021 4:05:14 PM;20210203160514

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - SARS-CoV-2 Antigen Test Kit Received CE Certification
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification
21-Dec-2020 3:00:25 PM;20201221150025

BTG

40024 NSX Nominated Adviser's Declaration - Annual Nominated Adviser Statement for 2020 - 2021 - Minerva Corporate Pty Ltd
Annual Nominated Adviser Statement for 2020 - 2021 - Minerva Corporate Pty Ltd
25-Nov-2020 12:45:20 PM;20201125124520

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Group Launches a New Probiotics Health Product
Beroni Group Launches a New Probiotics Health Product in China
10-Nov-2020 2:45:39 PM;20201110144539

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Named Top Infection Control Solutions Company
Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020
09-Nov-2020 4:06:27 PM;20201109160627

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Successful Completion of SARS-CoV-2 Assay
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
19-Oct-2020 2:20:30 PM;20201019142030

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Group Restructures in Japan
Beroni Group Restructures in Japan
01-Oct-2020 2:20:52 PM;20201001142052

BTG

Price Sensitive
40540 NSX Half Yearly Report - Half Year Report for the Year Ended 30 June 2020
Half Year Report for the Year Ended 30 June 2020
11-Sep-2020 5:28:45 PM;20200911172845

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Receives COVID-19 Test Kits Commercial Order
Beroni Group Receives First Commercial Order for its COVID-19 Test Kits from Japan
08-Sep-2020 11:21:33 AM;20200908112133

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Signs Agreement with Genscript Biotech
Beroni Group Signs Agreement with Genscript Biotech Corporation to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19
12-Aug-2020 2:10:42 PM;20200812141042

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Constructed Nanobodies for Coronavirus
Beroni Group has Successfully Constructed and Purified the 24 Types of Nanobodies for Rapid Detection and Treatment of Coronavirus
04-Aug-2020 2:30:58 PM;20200804143058

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni to Supply COVID-19 Antibody Test Kit to Japan
Beroni Group to Supply COVID-19 Antibody Test Kit to Japan
10-Jul-2020 3:00:46 PM;20200710150046

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Directors Interest-Richard Buchta
Initial Directors Interest-Richard Buchta
01-Jul-2020 11:18:58 AM;20200701111858

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration and Undertaking-Richard Buchta
Director's Declaration and Undertaking-Richard Buchta
01-Jul-2020 11:18:42 AM;20200701111842

BTG

41999 NSX General Market Disclosure Other - Dr Richard Buchta Appointed as Director of Beroni Group
Dr Richard Buchta Appointed as Director of Beroni Group
30-Jun-2020 11:37:10 AM;20200630113710

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in director's interest -Zhinan Yin
Change in director's interest -Zhinan Yin
23-Jun-2020 2:05:03 PM;20200623140503

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in director's interest -Libing Guo
Change in director's interest -Libing Guo
23-Jun-2020 2:04:28 PM;20200623140428

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in director's interest -Hai Huang
Change in director's interest -Hai Huang
23-Jun-2020 2:03:45 PM;20200623140345

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in director's interest -Peter Wong
Change in director's interest -Peter Wong
23-Jun-2020 2:02:37 PM;20200623140237

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in director's interests -Boqing Zhang
Change in director's interests -Boqing Zhang
23-Jun-2020 2:01:55 PM;20200623140155

BTG

Price Sensitive
40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
23-Jun-2020 7:15:38 AM;20200623071538

BTG

Price Sensitive
40315 NSX Placement - Issue of shares
Issue of shares to directors, employees and scientists
23-Jun-2020 7:14:09 AM;20200623071409

BTG

41999 NSX General Market Disclosure Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
01-Jun-2020 10:28:22 AM;20200601102822

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Issue of Shares
Issue of Shares
01-Jun-2020 10:28:05 AM;20200601102805

BTG

40930 NSX Results of Meeting - Results of Annual General Meeting
Results of Annual General Meeting
29-May-2020 1:11:46 PM;20200529131146

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Issue of US$2.97m Convertible Notes to Fund Growth
Beroni Group Issues US$2.97 million of Convertible Notes to Fund Growth Plans
27-May-2020 8:07:23 AM;20200527080723

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Identifies 24 Types of Nanobodies for COVID-19
Beroni Identifies 24 Types of Nanobodies for COVID-19
08-May-2020 1:20:31 PM;20200508132031

BTG

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
29-Apr-2020 11:58:23 AM;20200429115823

BTG

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
07-Apr-2020 1:59:32 PM;20200407135932

BTG

40315 NSX Placement - Issue of shares
Issue of shares
07-Apr-2020 1:59:28 PM;20200407135928

BTG

Price Sensitive
40051 NSX Reinstatement to Official Quotation - Removal of Trading Halt - Announcements released
Removal of Trading Halt - Announcements released
03-Apr-2020 2:06:29 PM;20200403140629

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - CE Certification Received for Covid-19 Test Kit
Beroni Group’s SARS-CoV-2 IgG/IgM Antibody Detection Kit received CE Certification
03-Apr-2020 1:04:25 PM;20200403130425

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Notifies FDA of Validated COVID19 Serology Test
Beroni Group Included in List of Commercial Manufacturers and Laboratories Who Have Notified US FDA of Validated Serology Tests for COVID-19
03-Apr-2020 1:00:12 PM;20200403130012

BTG

Price Sensitive
40030 NSX Trading Halt - Trading Halt - Company request pending announcement
Trading Halt - Company request pending announcement
03-Apr-2020 10:14:25 AM;20200403101425

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - 2019 Corporate Governance Statement
2019 Corporate Governance Statement
31-Mar-2020 1:31:23 PM;20200331133123

BTG

Price Sensitive
40510 NSX Annual Report - 2019 Annual Report
2019 Annual Report
31-Mar-2020 11:15:44 AM;20200331111544

BTG

Price Sensitive
40588 NSX Media Release - Submission of COVID-19 Rapid Test Kit to US FDA
Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit - Live Webcast at Virtual Life Sciences Investor Forum
26-Mar-2020 12:55:34 PM;20200326125534

BTG

Price Sensitive
40051 NSX Reinstatement to Official Quotation - Reinstatement to Official Quotation - Preliminary Final Report for 31 December 2019 lodged
Reinstatement to Official Quotation - Preliminary Final Report for 31 December 2019 lodged
17-Mar-2020 8:52:33 AM;20200317085233

BTG

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Annual Report 2019
Preliminary Annual Report 2019
16-Mar-2020 7:38:25 PM;20200316193825

BTG

Price Sensitive
40030 NSX Trading Halt - Trading Halt - Non-lodgement of Preliminary Final Report - 31 December 2019
Trading Halt - Non-lodgement of Preliminary Final Report - 31 December 2019
16-Mar-2020 10:01:10 AM;20200316100110

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Advances R&D of Medical Solution for COVID-19
Beroni Group Advances Research and Development of Medical Solution for Coronavirus (COVID-19) - Cytological Experiments Commenced in March 2020 - - Clinical Trials to Commence in April 2020 -
09-Mar-2020 12:05:25 PM;20200309120525

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni to Develop Novel Solution for Coronavirus
Beroni Group Collaborates with Tianjin University to Develop Novel Solution for Coronavirus (COVID-19)
20-Feb-2020 4:15:27 PM;20200220161527

BTG

41999 NSX General Market Disclosure Other - Beroni Featured in New Research Initiation Report
Beroni Group Featured in New Research Initiation Report
12-Feb-2020 7:38:30 AM;20200212073830

BTG

40315 NSX Placement - Application for quotation of Additional Securities
Application for quotation of Additional Securities
31-Jan-2020 1:00:09 PM;20200131130009

BTG

40315 NSX Placement - Issue of shares
Issue of shares
31-Jan-2020 12:59:25 PM;20200131125925

BTG

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
12-Dec-2019 2:32:31 PM;20191212143231

BTG

40315 NSX Placement - Issue of shares
Issue of shares
12-Dec-2019 2:32:28 PM;20191212143228

BTG

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
04-Dec-2019 8:59:29 AM;20191204085929

BTG

40315 NSX Placement - Issue of shares
Issue of shares
04-Dec-2019 8:59:12 AM;20191204085912

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni to Hold Third PMMCA International Forum
Beroni Group to Hold the Third Precision Medicine & Medical Care and Aging International Forum (with Conference Theme “Innovation Driving Development, Technology Leading Future”) in Tianjin, China on December 7-8, 2019
06-Nov-2019 8:50:24 AM;20191106085024

BTG

41999 NSX General Market Disclosure Other - Final Director’s Interest Notice
Final Director’s Interest Notice
31-Oct-2019 7:22:58 AM;20191031072258

BTG

40810 NSX Director Appointment/Resignation - Resignation of Director
Resignation of Director
31-Oct-2019 7:22:39 AM;20191031072239

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni to Launch US FDA Approved Virus Diagnostic Kit
Beroni Group to Launch its Advanced US FDA-Approved Virus Diagnostic Kit to Help Combat Global Outbreaks of Zika, Dengue, Chikungunya and West Nile Viruses
25-Oct-2019 11:11:30 AM;20191025111130

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni to Commercialise a Diagnostic Kit for 4 Viruses
Beroni USA is Ready to Commercialise a Diagnostic Kit for Detecting Zika, Dengue, Chikungunya and West Nile Viruses Worldwide
17-Sep-2019 2:05:41 PM;20190917140541

BTG

Price Sensitive
40550 NSX Half Yearly Report Audit Review - Half Year Report for the Year Ended 30 June 2019
Interim Financial Report For the Half Year Ended 30 June 2019
12-Sep-2019 4:06:52 PM;20190912160652

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Launches Japan-Made Stem Cell Skincare Products
Beroni Group Launches its First-Ever Japan-Made Stem Cell Based Regenerative Skincare Products in the Rapidly Growing Chinese Consumer Market
11-Sep-2019 12:21:03 PM;20190911122103

BTG

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
04-Sep-2019 11:13:59 AM;20190904111359

BTG

40315 NSX Placement - Beroni issues 200,000 New Shares
Beroni issues 200,000 New Shares to sophisticated investors
04-Sep-2019 11:13:55 AM;20190904111355

BTG

41999 NSX General Market Disclosure Other - Beroni Incorporate NewCo with UNSW to Develop PENAO
Beroni Group Incorporates New PENAO Company with University of New South Wales to Develop the Next Generation Anti-cancer Drug
28-Aug-2019 9:16:23 AM;20190828091623

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
20-Aug-2019 10:45:22 AM;20190820104522

BTG

41999 NSX General Market Disclosure Other - Beroni issues 110,000 New Shares to an existing Shareh
Beroni issues 110,000 New Shares to an existing Shareholder
20-Aug-2019 9:04:37 AM;20190820090437

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Beroni Secures DTC Eligibility for its Shares on OTCQX
Beroni Group Secures Eligibility by The Depository Trust Company (DTC) for its Shares on the OTCQX
14-Aug-2019 2:20:20 PM;20190814142020

BTG

41999 NSX General Market Disclosure Other - Cooperation with Jinshui Science & Education Park
Beroni Group Expands Into Strategic Relationship With Jinshui Science & Education Park In Zhengzhou, China
13-Aug-2019 1:43:04 PM;20190813134304

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Change in Directors Interests
Change in Directors Interests Boqing Zhang, Yap Ting Wong, Hai Huang, Libing Guo, Zhinan Yin
28-Jun-2019 7:45:17 AM;20190628074517

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
28-Jun-2019 7:42:09 AM;20190628074209

BTG

41999 NSX General Market Disclosure Other - Completion of issue of shares
Completion of issue of shares to Directors and employees
28-Jun-2019 7:40:15 AM;20190628074015

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration and Undertaking-Tameyuki Kawagu
Director's Declaration and Undertaking-Tameyuki Kawaguchi
14-Jun-2019 9:55:12 AM;20190614095512

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Strategic Cooperation Between Beroni Group and Profes
Strategic Cooperation Between Beroni Group and Professor Takuya Tsunoda
13-Jun-2019 12:00:14 PM;20190613120014

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration and Undertaking-Warwick Dawson
Director's Declaration and Undertaking-Warwick Dawson
12-Jun-2019 9:34:58 AM;20190612093458

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Joint Research Collaboration with Tianjin University
Strategic Joint Research Collaboration Between Beroni Group and Tianjin University
11-Jun-2019 10:30:14 AM;20190611103014

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Directors Interest-Tameyuki Kawaguchi
Initial Directors Interest-Tameyuki Kawaguchi
05-Jun-2019 11:10:13 AM;20190605111013

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Directors Interest-Warwick Dawson
Initial Directors Interest Warwick Dawson
05-Jun-2019 11:09:57 AM;20190605110957

BTG

41999 NSX General Market Disclosure Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
03-Jun-2019 4:12:26 PM;20190603161226

BTG

41999 NSX General Market Disclosure. Other - Issue of Shares
Issue of Shares
03-Jun-2019 4:11:38 PM;20190603161138

BTG

40810 NSX Director Appointment/Resignation - Appointment of Directors
Appointment of Directors
03-Jun-2019 10:01:36 AM;20190603100136

BTG

41999 NSX General Market Disclosure Other - Notification of Change in Auditor
Notification of Change in Auditor
31-May-2019 7:08:15 PM;20190531190815

BTG

40930 NSX Results of Meeting - Results of Annual General Meeting
Results of Annual General Meeting
31-May-2019 1:34:28 PM;20190531133428

BTG

40090 NSX Change to Basis of Quotation - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
13-May-2019 11:41:49 AM;20190513114149

BTG

40350 NSX Prospectus - Prospectus
Prospectus
10-May-2019 4:06:39 PM;20190510160639

BTG

41999 NSX General Market Disclosure Other - Appointment of Distributor
Appointment of Distributor
07-May-2019 3:15:13 PM;20190507151513

BTG

41999 NSX General Market Disclosure Other - Status of Medicine Plus Agreement
Status of Medicine Plus Agreement
01-May-2019 9:35:56 AM;20190501093556

BTG

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
30-Apr-2019 10:25:17 AM;20190430102517

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Quotation on OTCQX
Quotation on OTCQX
29-Apr-2019 11:13:02 AM;20190429111302

BTG

Price Sensitive
40460 NSX Agreement Notice - Exclusive License Agreement with Columbia University
Exclusive License Agreement with Columbia University
26-Apr-2019 8:16:21 AM;20190426081621

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Notice of final Director Notice -Changbin Deng
Notice of final Director Notice -Changbin Deng
16-Apr-2019 11:55:30 AM;20190416115530

BTG

40810 NSX Director Appointment/Resignation - Resignation of Non-Executive Director
Resignation of Non-Executive Director - Changbin Deng
16-Apr-2019 6:26:43 AM;20190416062643

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - 2018 Corporate Governance Statement
2018 Corporate Governance Statement
28-Mar-2019 4:15:32 PM;20190328161532

BTG

Price Sensitive
40510 NSX Annual Report - 2018 Annual Report
2018 Annual Report
28-Mar-2019 4:05:55 PM;20190328160555

BTG

40750 NSX Details of Share Registry - Change of Share Registry
Change of Share Registry
26-Mar-2019 5:27:40 PM;20190326172740

BTG

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Annual Report FY2018
Preliminary Annual Report 2018
15-Mar-2019 3:27:22 PM;20190315152722

BTG

40930 NSX Results of Meeting - Results of Extraordinary General Meeting
Results of Extraordinary General Meeting
30-Nov-2018 4:06:12 PM;20181130160612

BTG

41999 NSX General Market Disclosure Other - Update on Transaction Documents with Cystemix
Update on Transaction Documents with Cystemix
30-Nov-2018 9:08:17 AM;20181130090817

BTG

41999 NSX General Market Disclosure Other - Extension of Settlement Date with Medicine Plus
Extension of Settlement Date with Medicine Plus
27-Nov-2018 11:14:37 AM;20181127111437

BTG

41999 NSX General Market Disclosure Other - Status of Medicine Plus Agreement
Status of Medicine Plus Agreement
21-Nov-2018 9:43:38 AM;20181121094338

BTG

40730 NSX Details of Registered Office - Change of Registered Office address
Change of Registered Office address
26-Oct-2018 2:39:00 PM;20181026143900

BTG

40920 NSX Notice of Extraordinary Meeting - Notice of Extraordinary Meeting
Notice of Extraordinary Meeting
25-Oct-2018 8:23:47 AM;20181025082347

BTG

41999 NSX General Market Disclosure Other - Strategic Review
Strategic Review
23-Oct-2018 11:54:25 AM;20181023115425

BTG

41999 NSX General Market Disclosure Other - Deferral of Investment into Dendrix Inc
Deferral of Investment into Dendrix Inc
17-Oct-2018 10:01:08 AM;20181017100108

BTG

40120 NSX Change in Substantial Shareholder - Change in Substantial Shareholder - Beroni Technolgy Ltd
Change in Substantial Shareholder - Beroni Technology Ltd
09-Oct-2018 3:10:53 PM;20181009151053

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Issue of Shares for Medicine Plus
Issue of Shares for Medicine Plus
08-Oct-2018 12:36:34 PM;20181008123634

BTG

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
08-Oct-2018 12:50:37 PM;20181008125037

BTG

41999 NSX General Market Disclosure Other - Update on Sponsored Research Agreement with CU
Update on Sponsored Research Agreement with Columbia University
01-Oct-2018 8:43:12 AM;20181001084312

BTG

41999 NSX General Market Disclosure Other - Removal of Trading from Frankfurt Stock Exchange
Removal of Trading from Frankfurt Stock Exchange
24-Sep-2018 2:46:52 PM;20180924144652

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Extension of Payment Date for Medicine Plus Transactio
Extension of Payment Date for Medicine Plus Transaction
21-Sep-2018 8:42:49 AM;20180921084249

BTG

Price Sensitive
40540 NSX Half Yearly Report - 2018 Interim Financial Report
2018 Interim Financial Report
07-Sep-2018 1:55:35 PM;20180907135535

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Sales and Service Agreements with Beijing Youlian
Sales and Service Agreements with Beijing Youlian ENT Hospital
28-Aug-2018 9:34:08 AM;20180828093408

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Strategic Partnership with I'rom Group
Strategic Partnership with I'rom Group
22-Aug-2018 8:57:47 AM;20180822085747

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Clinical Trial Development of PENAO
Clinical Trial Development of PENAO
21-Aug-2018 10:08:13 AM;20180821100813

BTG

40024 NSX Nominated Adviser's Declaration - Annual Nominated Adviser Statement for 2018-2019 - Minerva Corporate Pty Ltd
Annual Nominated Adviser Statement for 2018-2019 - Minerva Corporate Pty Ltd
03-Aug-2018 10:11:30 AM;20180803101130

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Extension of Exclusivity period with Cystemix
Extension of Exclusivity period with Cystemix
01-Aug-2018 12:37:11 PM;20180801123711

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - Dr Zhinan Yin
Director's Declaration & Undertaking - Dr Zhinan Yin
19-Jul-2018 9:46:42 AM;20180719094642

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Notice of Initial Director's Interests
Notice of Initial Director's Interests- Dr Zhinan Yin
02-Jul-2018 9:09:31 AM;20180702090931

BTG

Price Sensitive
40810 NSX Director Appointment/Resignation - Appointment of Director
Appointment of Director-Dr Zhinan Yin
02-Jul-2018 9:09:23 AM;20180702090923

BTG

Price Sensitive
40460 NSX Agreement Notice - Beroni Group to Acquire Medicine Plus
Beroni Group to Acquire Medicine Plus
20-Jun-2018 4:25:46 PM;20180620162546

BTG

40150 NSX Section 205G Notice Change in Director's Interests - Notice of Change in Directors' Interests
Notice of Change in Directors' Interests- Mr Boqing Zhang, Mr Yap Ting Wong, Mr Hai Huang, Mr Libing Guo, and Mr Changbin Deng
19-Jun-2018 10:56:56 AM;20180619105656

BTG

40399 NSX Issued Capital Other - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
19-Jun-2018 9:33:31 AM;20180619093331

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Completion of issue of shares
Completion of issue of shares to Directors and Company Secretary
19-Jun-2018 9:33:04 AM;20180619093304

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Investment into Youtokukai
Investment into Youtokukai
18-Jun-2018 1:03:45 PM;20180618130345

BTG

40110 NSX Becoming a Substantial Shareholder - Notice of initial substantial holder
Notice of initial substantial holder- Kai Shen
08-Jun-2018 7:44:23 AM;20180608074423

BTG

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
08-Jun-2018 7:41:57 AM;20180608074157

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Placement of Shares
BTG has completed the placement of shares
08-Jun-2018 7:40:10 AM;20180608074010

BTG

40120 NSX Change in Substantial Shareholder - Change of interest of Substantial Holder
Change of interest of Substantial Holder
01-Jun-2018 4:02:56 PM;20180601160256

BTG

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities-Placement of 3,751,887 shares
01-Jun-2018 3:20:41 PM;20180601152041

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Completion of Capital Raising
Completion of Capital Raising and issue of shares
01-Jun-2018 3:20:37 PM;20180601152037

BTG

40930 NSX Results of Meeting - Results of Annual General Meeting
Results of Annual General Meeting
30-May-2018 12:37:59 PM;20180530123759

BTG

40320 NSX Issues to Public - Application for Quotation of Securities - Release of 12 month Escrow
Application for Quotation of Securities - Release of 12 month Escrow
15-May-2018 9:45:35 AM;20180515094535

BTG

Price Sensitive
40081 NSX Response to Query - Response to Price Query
Response to Price Query
15-May-2018 9:35:21 AM;20180515093521

BTG

Price Sensitive
40080 NSX Query - Price Query
Price Query
15-May-2018 9:35:18 AM;20180515093518

BTG

Price Sensitive
40081 NSX Response to Query - Response to NSX Continuous Disclosure Query
Response to Continuous Disclosure Query
10-May-2018 10:16:03 AM;20180510101603

BTG

Price Sensitive
40080 NSX Query - NSX Continuous Disclosure Query
Continuous Disclosure Query
10-May-2018 10:15:50 AM;20180510101550

BTG

40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting
Notice of Annual General Meeting
30-Apr-2018 9:59:53 AM;20180430095953

BTG

40120 NSX Change in Substantial Shareholder - Change of interest of Substantial Holder - Beroni Techology Limited
Change of interest of Substantial Holder - Beroni Technology Limited
12-Apr-2018 9:02:29 AM;20180412090229

BTG

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
11-Apr-2018 4:28:31 PM;20180411162831

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Completion of Capital Raising and Issue of Shares
Completion of Capital Raising and Issue of Shares
11-Apr-2018 10:15:21 AM;20180411101521

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Investment into Dendrix Inc
Investment into Dendrix Inc
09-Apr-2018 1:45:52 PM;20180409134552

BTG

41999 NSX General Market Disclosure Other - 2017 Corporate Governance Statement
2017 Corporate Governance Statement
29-Mar-2018 10:57:44 AM;20180329105744

BTG

Price Sensitive
40510 NSX Annual Report - 2017 Annual Report
2017 Annual Report
29-Mar-2018 10:55:04 AM;20180329105504

BTG

Price Sensitive
40460 NSX Agreement Notice - Signing of Investment Term Sheet with UNSW
Signing of Investment Term Sheet with UNSW
28-Mar-2018 2:50:07 PM;20180328145007

BTG

Price Sensitive
40460 NSX Agreement Notice - Sponsored Research Agreement with Columbia University
Sponsored Research Agreement with Columbia University
26-Mar-2018 9:13:48 AM;20180326091348

BTG

Price Sensitive
40530 NSX Preliminary/Final Statement - Preliminary Annual Report FY2017
Preliminary Annual Report FY2017
16-Mar-2018 9:40:29 AM;20180316094029

BTG

Price Sensitive
40051 NSX Reinstatement to Official Quotation - Removal of Suspension
Removal of Suspension
15-Mar-2018 11:29:54 AM;20180315112954

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Product Update and Strategy Forward
Product Update and Strategy Forward
15-Mar-2018 11:24:23 AM;20180315112423

BTG

41999 NSX General Market Disclosure Other - Extension of Exclusive Period with UNSW
Extension of Exclusive Period with UNSW
26-Feb-2018 12:15:27 PM;20180226121527

BTG

40024 NSX Nominated Adviser's Declaration - Nominated Adviser's Declaration
Nominated Adviser's Declaration
26-Feb-2018 6:53:46 AM;20180226065346

BTG

41999 NSX General Market Disclosure Other - Appointment of Minerva Corporate as Nominated Advisor
Appointment of Minerva Corporate as Nominated Advisor
26-Feb-2018 6:53:39 AM;20180226065339

BTG

Price Sensitive
40050 NSX Suspension from Official Quotation - Voluntary Suspension Request
Voluntary Suspension Request
05-Feb-2018 5:58:29 PM;20180205175829

BTG

Price Sensitive
40030 NSX Trading Halt - Request for Trading Halt - Update
Correction to Exchange Code
01-Feb-2018 5:55:15 PM;20180201175515

BTG

Price Sensitive
40030 NSX Trading Halt - Request for Trading Halt
Company request for immediate trading halt
01-Feb-2018 5:25:50 PM;20180201172550

BTG

41999 NSX General Market Disclosure Other - Dual Listed on Frankfurt Stock Exchange
Dual Listed on Frankfurt Stock Exchange
19-Jan-2018 10:51:47 AM;20180119105147

BTG

40120 NSX Change in Substantial Shareholder - Change of Interest of Substantial Holder
Change of Interest of Substantial Holder
27-Dec-2017 8:42:43 AM;20171227084243

BTG

Price Sensitive
40315 NSX Placement - Completion of Capital Raising and Issue of Shares
Completion of Capital Raising and Issue of Shares
18-Dec-2017 10:14:11 AM;20171218101411

BTG

40315 NSX Placement - Application for Quotation of Additional Securities
Application for Quotation of Additional Securities
18-Dec-2017 10:14:21 AM;20171218101421

BTG

Price Sensitive
41999 NSX General Market Disclosure Other - Letter of Intent with UNSW
Letter of Intent with UNSW
03-Nov-2017 6:24:07 AM;20171103062407

BTG

Price Sensitive
40540 NSX Half Yearly Report - Beroni Group Limited Half Year report
Beroni Group Limited Half Year report
11-Sep-2017 5:11:18 PM;20170911171118

BTG

40081 NSX Response to Query - Response to NSX General Query
Response to NSX General Query
11-Sep-2017 4:36:51 PM;20170911163651

BTG

40024 NSX Nominated Adviser's Declaration - Nominated Adviser's Declaration
Nominated Adviser's Declaration
26-Jul-2017 2:03:37 PM;20170726140337

BTG

Price Sensitive
40081 NSX Response to Query - Response to Price Query
Response to Price Query
05-Jul-2017 4:33:34 PM;20170705163334

BTG

Price Sensitive
40080 NSX Query - Price Query - 4th of July 2017
Price Query - 4th of July 2017
05-Jul-2017 4:33:23 PM;20170705163323

BTG

40399 NSX Issued Capital Other - Updated Top 20 Shareholders
Updated Top 20 Shareholders
28-Jun-2017 3:14:53 PM;20170628151453

BTG

40024 NSX Nominated Adviser's Declaration - Nominated Adviser's Declaration
Nominated Adviser's Declaration
21-Jun-2017 12:58:23 PM;20170621125823

BTG

Price Sensitive
40081 NSX Response to Query - Response to Price Query and Continuous Disclosure Query
Response to Price Query and Continuous Disclosure Query
21-Jun-2017 12:48:40 PM;20170621124840

BTG

Price Sensitive
40080 NSX Query - Price Query and Continuous Disclosure Query - 19th of June 2017
Price Query and Continuous Disclosure Query - 19th of June 2017
21-Jun-2017 12:47:41 PM;20170621124741

BTG

40816 NSX Nominated Adviser Appointment/Resignation - Appointment of AGC Capital as Nominated Adviser
Appointment of AGC Capital Securities as nominated Adviser.
21-Jun-2017 7:00:38 AM;20170621070038

BTG

41999 NSX General Market Disclosure Other - Memorandum of Cooperation with Eugene Institute
Beroni Group Limited and Eugene Institute of Biomedicine have signed a cooperation agreement to form a strategic relationship on scientific knowledge-share and technology development.
19-May-2017 11:55:38 AM;20170519115538

BTG

40110 NSX Becoming a Substantial Shareholder - Notice of Substantial Shareholder - Beroni Technology Ltd
Notice of Substantial Shareholder - Beroni Technology Ltd
12-May-2017 2:01:51 PM;20170512140151

BTG

40024 NSX Nominated Adviser's Declaration - Nominated Adviser's Declaration
Nominated Adviser's Declaration
10-May-2017 2:40:42 PM;20170510144042

BTG

40099 NSX Official List Other - Issuer Undertaking
Issuer Undertaking
10-May-2017 2:39:26 PM;20170510143926

BTG

40520 NSX Top 20 Shareholders - Top 20 Shareholders
Top 20 Shareholders
10-May-2017 2:39:18 PM;20170510143918

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration - Boqing Zhang
Director's Declaration - Boqing Zhang
10-May-2017 2:39:07 PM;20170510143907

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Declaration -Boqing Zhang
Initial Director's Declaration -Boqing Zhang
10-May-2017 2:38:59 PM;20170510143859

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration - Peter Wong
Director's Declaration - Peter Wong
10-May-2017 2:38:49 PM;20170510143849

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Declaration -Peter Wong
Initial Director's Declaration -Peter Wong
10-May-2017 2:38:41 PM;20170510143841

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration -Hai Huang
Director's Declaration -Hai Huang
10-May-2017 2:38:27 PM;20170510143827

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - Hai Huang
Initial Director's Interests - Hai Huang
10-May-2017 2:38:15 PM;20170510143815

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration - Libing Guo
Director's Declaration - Libing Guo
10-May-2017 2:37:56 PM;20170510143756

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Declaration - Libing Guo
Initial Director's Declaration - Libing Guo
10-May-2017 2:37:29 PM;20170510143729

BTG

40023 NSX Director's Declaration & Undertaking - Director's Declaration - Chris Deng
Director's Declaration - Chris Deng
10-May-2017 2:37:08 PM;20170510143708

BTG

40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - Chris Deng
Initial Director's Interests - Chris Deng
10-May-2017 2:36:53 PM;20170510143653

BTG

40099 NSX Official List Other - Financials - 21 May 2014 to 30 June 2016
Financials - 21 May 2014 to 30 June 2016
10-May-2017 2:28:16 PM;20170510142816

BTG

40022 NSX Articles of Association/Constitution - Company Constitution
Company Constitution
10-May-2017 2:26:59 PM;20170510142659

BTG

40350 NSX Prospectus - Prospectus
Prospectus
10-May-2017 2:26:19 PM;20170510142619

BTG

40350 NSX Prospectus - Supplementary Prospectus
Supplementary Prospectus
10-May-2017 1:59:07 PM;20170510135907

BTG

40350 NSX Prospectus - Second Supplementary Prospectus
Second Supplementary Prospectus
10-May-2017 1:58:31 PM;20170510135831

BTG

40350 NSX Prospectus - Third Supplementary Prospectus
Third Supplementary Prospectus
10-May-2017 1:57:55 PM;20170510135755

BTG

40350 NSX Prospectus - Fourth Supplementary Prospectus
Fourth Supplementary Prospectus
10-May-2017 1:57:15 PM;20170510135715

BTG

40099 NSX Official List Other - Listing Application
Listing Application
10-May-2017 1:55:58 PM;20170510135558

BTG

40020 NSX Commencement of Official Quotation - Commencement of Quotation - Beroni Group Limited - BTG - 11am, Friday, 12th of May, 2017
Commencement of Quotation - Beroni Group Limited - BTG - 11am, Friday, 12th of May, 2017
10-May-2017 1:54:45 PM;20170510135445